171 results
Page 4 of 9
8-K
0wdirpx s61l4hf5p5d
15 Mar 21
Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer
4:11pm
8-K
EX-1.1
56kkbp2h8r0342l
9 Feb 21
Entry into a Material Definitive Agreement
6:01am
8-K
EX-10.1
wy7zn5mn 1y4dn
8 Feb 21
Entry into a Material Definitive Agreement
9:55pm
8-K
oajb26d4qrf0u3c o3j
14 Dec 20
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
5:15pm
8-K
EX-10.2
12t23llnv e5txfim
9 Jun 20
Departure of Directors or Certain Officers
5:21pm
8-K
EX-1.1
i4c3c71 ivhswxtht
29 May 20
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
4:22pm
424B5
5knea filp
29 May 20
Prospectus supplement for primary offering
4:15pm
424B5
z9kanhb8dcomym97
27 May 20
Prospectus supplement for primary offering
5:26pm
S-3ASR
EX-4.1
yr1 ot937wne0t6lwkn
27 May 20
Automatic shelf registration
4:14pm
8-K
EX-99.2
fky0dx
8 May 20
In the United States District Court for the District of Delaware
5:17pm
8-K
EX-99.1
lds3l j9w
8 May 20
In the United States District Court for the District of Delaware
5:17pm